{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:46:53Z","timestamp":1773924413193,"version":"3.50.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>25-60% of septic patients experience relative adrenal insufficiency (RAI) and glucocorticoid (GC) is frequently used in septic patients. However, the efficacy of GC therapy and whether GC therapy should be based on the status of RAI are highly controversial. Our poor understanding about the pathogenesis of RAI and a lack of RAI animal model present significant barriers to address these critical issues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Scavenger receptor BI (SR-BI) regulates stress-induced GC (iGC) production in response to stress. We generated SF1CreSR-BIfl\/fl mice and utilized the mice as a RAI model to elucidate the pathogenesis of RAI and GC therapy in sepsis. SF1CreSR-BIfl\/fl mice did not express SR-BI in adrenal gland and lacked iGC production upon ACTH stimulation, thus, they are RAI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>RAI mice were susceptible to cecal ligation and puncture (CLP)-induced sepsis (6.7% survival in SF1CreSR-BIfl\/fl mice versus 86.4% in SR-BIfl\/fl mice; p = 0.0001). Compared to a well-controlled systemic inflammatory response in SR-BIfl\/fl mice, SF1CreSR-BIfl\/fl mice featured a persistent hyperinflammatory response. Supplementation of a low stress dose of GC to SF1CreSR-BIfl\/fl mice kept the inflammatory response under control and rescued the mice. However, SR-BIfl\/fl mice receiving GC treatment exhibited significantly less survival compared to SR-BIfl\/fl mice without GC treatment. In conclusions, we demonstrated that RAI is a risk factor for death in this mouse model of sepsis. We further demonstrated that RAI is an endotype of sepsis, which features persistent hyperinflammatory response. We found that GC treatment benefits mice with RAI but harms mice without RAI. Our study provides a proof of concept to support a precision medicine approach for sepsis therapy \u2013 selectively applying GC therapy for a subgroup of patients with RAI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1110516","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T07:08:53Z","timestamp":1673507333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Relative adrenal insufficiency is a risk factor and endotype of sepsis - A proof-of-concept study to support a precision medicine approach to guide glucocorticoid therapy for sepsis"],"prefix":"10.3389","volume":"13","author":[{"given":"Chia-Hua","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Mineo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-An","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of global incidence and mortality of hospital-treated sepsis","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Curr Estimates Limitations. Am J Respir Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the united states: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: Testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1887","article-title":"The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome","volume":"101","author":"Aird","year":"2003","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.66","article-title":"Sepsis: Revising definitions of sepsis","volume":"11","author":"Drewry","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1369OC","article-title":"Diagnosis of adrenal insufficiency in severe sepsis and septic shock","volume":"174","author":"Annane","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200301000-00022","article-title":"Adrenal insufficiency during septic shock","volume":"31","author":"Marik","year":"2003","journal-title":"Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"Jama"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: The HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1803563","article-title":"Long-term outcomes of the ADRENAL trial","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-012-2720-z","article-title":"Low-dose steroids in adult septic shock: results of the surviving sepsis campaign","volume":"38","author":"Casserly","year":"2012","journal-title":"Intensive Care Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2110-5820-1-7","article-title":"Corticosteroids for severe sepsis: an evidence-based guide for physicians","volume":"1","author":"Annane","year":"2011","journal-title":"Ann Intensive Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/cc2878","article-title":"Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids","volume":"8","author":"Prigent","year":"2004","journal-title":"Crit Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.255034","article-title":"Serum cortisol: An up-To-Date assessment of routine assay performance","volume":"62","author":"Hawley","year":"2016","journal-title":"Clin Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0265","article-title":"Septic shock and sepsis: a comparison of total and free plasma cortisol levels","volume":"91","author":"Ho","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000046","article-title":"Scavenger receptor class b type i and immune dysfunctions","volume":"21","author":"Zheng","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000219310.00308.10","article-title":"Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxin-induced death","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.020933","article-title":"Scavenger receptor BI protects against septic death through its role in modulating inflammatory response","volume":"284","author":"Guo","year":"2009","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M023234","article-title":"Macrophage SR-BI regulates pro-inflammatory signaling in mice and isolated macrophages","volume":"53","author":"Cai","year":"2012","journal-title":"J Lipid Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314506","article-title":"SR-BI (Scavenger receptor BI), not LDL (Low-density lipoprotein) receptor, mediates adrenal stress response-brief report","volume":"40","author":"Ito","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303164","article-title":"Adrenocortical scavenger receptor class b type i deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice","volume":"193","author":"Gilibert","year":"2014","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26893","article-title":"Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues","volume":"116","author":"Huby","year":"2006","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001264","article-title":"Corticosteroid therapy benefits septic mice with adrenal insufficiency but harms septic mice without adrenal insufficiency*","volume":"43","author":"Ai","year":"2015","journal-title":"Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1140-4","article-title":"SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis","volume":"569","author":"Huang","year":"2019","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.234716","article-title":"Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice","volume":"31","author":"Feng","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"22637","DOI":"10.1038\/srep22637","article-title":"Age-associated metabolic dysregulation in bone marrow-derived macrophages stimulated with lipopolysaccharide","volume":"6","author":"Fei","year":"2016","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3205","article-title":"Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation","volume":"16","author":"Su","year":"2015","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411760200","article-title":"The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-048215","article-title":"Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase","volume":"109","author":"Bhattacharyya","year":"2007","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving sepsis campaign guidelines for management of severe sepsis and septic shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the american college of critical care medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MED.0b013e3283307d53","article-title":"Relative adrenal insufficiency","volume":"16","author":"Loriaux","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","article-title":"Why have clinical trials in sepsis failed","volume":"20","author":"Marshall","year":"2014","journal-title":"Trends Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003225","article-title":"Surviving sepsis campaign: Research priorities for sepsis and septic shock","volume":"46","author":"Coopersmith","year":"2018","journal-title":"Crit Care Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002028","article-title":"Precision medicine for critical illness and injury","volume":"44","author":"Buchman","year":"2016","journal-title":"Crit Care Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/01.ccm.0000510159.48167.31","article-title":"Glucocorticoid only benefits septic mice with adrenal insufficiency: A precision medicine approach","volume":"44","author":"Li","year":"2016","journal-title":"Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2004.2016.043976","DOI":"10.1101\/2020.04.16.043976","article-title":"Relative adrenal insufficiency is a risk factor and an endotype of sepsis - a proof of concept study to support a precision medicine approach for glucocorticoid sepsis therapy","volume":"2020","author":"Wu","year":"2020","journal-title":"BioRxiv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1114866","article-title":"Preparing for precision medicine","volume":"366","author":"Mirnezami","year":"2012","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"New Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"B51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1472-6823-14-91","article-title":"Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers","volume":"14","author":"Jung","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0228-0","article-title":"The human stress response","volume":"15","author":"Russell","year":"2019","journal-title":"Nat Rev Endocrinol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1110516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T07:08:57Z","timestamp":1673507337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1110516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2022.1110516"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1110516","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1110516"}}